The advancement of innovative drug treatments hinges on efficient and reliable logistics solutions. Biocair, a global leader in life science logistics, has played a pivotal role in accelerating drug development timelines through its expertise in handling complex shipments of active pharmaceutical ingredients (APIs).
n a recent case, Biocair supported a US-based research company in transporting temperature-sensitive APIs from China to the US. Despite corporate transitions and regulatory challenges, Biocair's customized cold chain solutions and expert support ensured the integrity and timely delivery of critical shipments, facilitating the research company’s progression from pre-clinical research to FDA approval.
Ensuring the regularity of shipments is critical. Patients need precise dosages at specific times to maintain the integrity of the clinical trial. Clinical trial integrity has been key to the new drug treatment attaining approval by the FDA. From initial research, through clinical trials to commercialization, the continued supply of validated packaging and personalized transportation solutions remains vital.
“Biocair’s ability to manage the complexities of international shipping and regulatory requirements was instrumental in keeping this project on track,”,
says Thomas Pettit, Vice President of Customer Solutions at Biocair.
“We didn’t want to overly complicate the pack out process because it’s completed by teams across China and the United States. It needed to be easy to learn if transferred over to another facility or if demand increased. Keeping the procedure simple reduces training time and allows it to be accurately and consistently repeated.”
By simplifying packaging procedures and navigating complex customs regulations, Biocair maintained shipment integrity and regularity, crucial for clinical trial success. Their strategic support enabled consistent supply and overcame logistical hurdles, proving vital to the expedited development of new drug treatments.
"In advanced programs with a global supplier footprint, our clients need a logistics supplier that can execute swiftly. Partnering with Biocair ensures critical program timelines are met,"
says Pettit.
For more information about the critical impact of logistics on drug development, please visit here: https://hubs.li/Q02DhCsL0
--
About Biocair
Since 1986, Biocair has established a global reputation as a leading GDP logistics specialist within the pharmaceutical, biotechnology and life sciences sectors. Biocair has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost-effective solutions to all its clients. It is committed to delivering complete end-to-end logistics solutions through its 24/7 operation and global network spanning across Europe, Africa, Asia and the Americas.
Biocair employs over 550 people worldwide and provides specialist logistics services to more than 160 countries through a global network of partners. Biocair’s offices are located in the UK, France, Belgium, Germany, USA, South Africa, China, Singapore and India.
In 2012 Biocair was acquired as an autonomous division by Geopost. Geopost is the largest parcel delivery network in Europe, which posted sales of €15.69 billion in 2023. Geopost is a holding company owned by Groupe La Poste.
For further information on Biocair, please visit www.biocair.com.
